{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:18:33Z","timestamp":1793161113091,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Health Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To evaluate the safety and efficacy of the PAUL Glaucoma Implant (PGI) for managing refractory primary congenital glaucoma (PCG) over a one-year period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Study Design<\/jats:title>\n                <jats:p>Retrospective.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A study was conducted using the medical records of thirty eyes of 17 patients who underwent PGI surgery for the treatment of refractory PCG. Primary outcome measures included failure criteria such as intraocular pressure (IOP)\u2009&gt;\u200921\u00a0mm Hg, &lt;\u200920% IOP reduction, necessity for further glaucoma intervention, implant removal, or loss of vision. Secondary outcomes focused on mean IOP, average number of glaucoma medications, best corrected visual acuity (logMAR), and incidence of complications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The mean preoperative IOP of 38.8\u2009\u00b1\u20099.2 mmHg significantly decreased to 16.1\u2009\u00b1\u20093.3 mmHg at 12 months postoperatively (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The average number of glaucoma medications reduced from 3.6\u2009\u00b1\u20090.5 preoperatively to 0.9\u2009\u00b1\u20091.2 at 12 months post-op. Visual acuity remained stable in 24 eyes, decreased in 4, and increased in 2. Early postoperative complications occurred in 13.3% of patients, but no late complications were reported. The cumulative success rate was 86.6%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The PGI appears to be a safe and effective option for managing refractory primary congenital glaucoma, demonstrating significant IOP reduction and decreased dependence on glaucoma medications over a one-year period, with a high success rate and manageable complication profile.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10384-024-01076-0","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T09:03:37Z","timestamp":1719479017000},"page":"571-577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy and safety of the paul glaucoma implant in the treatment of refractory primary congenital glaucoma"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9604-6887","authenticated-orcid":false,"given":"Murat","family":"Karapapak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Olgun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"key":"1076_CR1","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1001\/archopht.1984.01040031081030","volume":"102","author":"HD Hoskins","year":"1984","unstructured":"Hoskins HD, Shaffer RN, Hetherington J. Anatomical classification of the developmental glaucomas. Arch Ophthalmol. 1984;102:1331\u20136.","journal-title":"Arch Ophthalmol"},{"key":"1076_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0039-6257(83)90174-1","volume":"28","author":"VP deLuise","year":"1983","unstructured":"deLuise VP, Anderson DR. Primary infantile glaucoma (congenital glaucoma). Surv Ophthalmol. 1983;28:1\u201319.","journal-title":"Surv Ophthalmol"},{"key":"1076_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/01.icu.0000193091.60185.27","volume":"17","author":"SA Tanimoto","year":"2006","unstructured":"Tanimoto SA, Brandt JD. Options in pediatric glaucoma after angle surgery has failed. Curr Opin Ophthalmol. 2006;17:132\u20137.","journal-title":"Curr Opin Ophthalmol"},{"key":"1076_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/00061198-200406000-00010","volume":"13","author":"AM Rodrigues","year":"2004","unstructured":"Rodrigues AM, Junior AP, Montezano FT, de Arruda Melo PA, Junior JP. Comparison between results of trabeculectomy in primary congenital Glaucoma with and without the Use of Mitomycin C. J Glaucoma. 2004;13:228\u201332.","journal-title":"J Glaucoma"},{"key":"1076_CR5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/bjo.80.6.499","volume":"80","author":"T Fulcher","year":"1996","unstructured":"Fulcher T, Chan J, Lanigan B, Bowell R, O\u2019Keefe M. Long-term follow up of primary trabeculectomy for infantile glaucoma. Br J Ophthalmol. 1996;80:499\u2013502.","journal-title":"Br J Ophthalmol"},{"key":"1076_CR6","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/S0161-6420(97)30195-X","volume":"104","author":"AK Mandal","year":"1997","unstructured":"Mandal AK, Walton DS, John T, Jayagandan A. Mitomycin C-augmented trabeculectomy in refractory congenital Glaucoma. Ophthalmology. 1997;104:996\u20131003.","journal-title":"Ophthalmology"},{"key":"1076_CR7","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0161-6420(98)91041-7","volume":"105","author":"A Al-Hazmi","year":"1998","unstructured":"Al-Hazmi A, Zwaan J, Awad A, Al-Mesfer S, Mullaney PB, Wheeler DT. Effectiveness and complications of mitomycin C use during pediatric glaucoma surgery. Ophthalmology. 1998;105:1915\u201320.","journal-title":"Ophthalmology"},{"key":"1076_CR8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S0161-6420(99)00130-X","volume":"107","author":"PA Sidoti","year":"2000","unstructured":"Sidoti PA, Belmonte SJ, Liebmann JM, Ritch R. Trabeculectomy with mitomycin-c in the treatment of pediatric glaucomas. Ophthalmology. 2000;107:422\u20139.","journal-title":"Ophthalmology"},{"key":"1076_CR9","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.ophtha.2007.03.080","volume":"114","author":"O Roche","year":"2007","unstructured":"Roche O, Beby F, Parsa A, Orssaud C, Dufier JL, Parsa CF. Nonpenetrating external trabeculectomy for congenital glaucoma. Ophthalmology. 2007;114:1994\u20139.","journal-title":"Ophthalmology"},{"key":"1076_CR10","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jaapos.2014.08.008","volume":"18","author":"MR Razeghinejad","year":"2014","unstructured":"Razeghinejad MR, Kaffashan S, Nowroozzadeh MH. Results of Ahmed glaucoma valve implantation in primary congenital glaucoma. J Am Association Pediatr Ophthalmol Strabismus. 2014;18:590\u20135.","journal-title":"J Am Association Pediatr Ophthalmol Strabismus"},{"key":"1076_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3928\/1542-8877-19950901-05","volume":"26","author":"MJ Phelan","year":"1995","unstructured":"Phelan MJ, Higginbotham EJ. Contact transscleral nd:YAG laser cyclophotocoagulation for the treatment of refractory pediatric glaucoma. Ophthalmic Surg Lasers. 1995;26:401\u20133.","journal-title":"Ophthalmic Surg Lasers"},{"key":"1076_CR12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ogla.2020.05.001","volume":"3","author":"V Koh","year":"2020","unstructured":"Koh V, Chew P, Triolo G, Lim KS, Barton K, Koh V, et al. Treatment outcomes using the PAUL glaucoma implant to control intraocular pressure in eyes with refractory glaucoma. Ophthalmol Glaucoma. 2020;3:350\u20139.","journal-title":"Ophthalmol Glaucoma"},{"key":"1076_CR13","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1038\/s41433-021-01737-1","volume":"36","author":"NA Vallabh","year":"2022","unstructured":"Vallabh NA, Mason F, Yu JTS, Yau K, Fenerty CH, Mercieca K, et al. Surgical technique, perioperative management and early outcome data of the PAUL\u00ae glaucoma drainage device. Eye. 2022;36:1905\u201310.","journal-title":"Eye"},{"key":"1076_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/08820538.2020.1781906","volume":"35","author":"AM Elhusseiny","year":"2020","unstructured":"Elhusseiny AM, VanderVeen DK. Outcomes of glaucoma drainage devices in childhood glaucoma. Semin Ophthalmol. 2020;35:194\u2013204.","journal-title":"Semin Ophthalmol"},{"key":"1076_CR15","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.survophthal.2023.01.010","volume":"68","author":"JY Stallworth","year":"2023","unstructured":"Stallworth JY, O\u2019Brien KS, Han Y, Oatts JT. Efficacy of Ahmed and Baerveldt glaucoma drainage device implantation in the pediatric population: a systematic review and meta-analysis. Surv Ophthalmol. 2023;68:578\u201390.","journal-title":"Surv Ophthalmol"},{"key":"1076_CR16","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1001\/archophthalmol.2009.267","volume":"127","author":"Y Ou","year":"2009","unstructured":"Ou Y, Yu F, Law SK, Coleman AL, Caprioli J. Outcomes of Ahmed glaucoma valve implantation in children with primary congenital glaucoma. Arch Ophthalmol. 2009;127:1436\u201341.","journal-title":"Arch Ophthalmol"},{"key":"1076_CR17","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3928\/01913913-20230119-02","volume":"60","author":"AH Badawi","year":"2023","unstructured":"Badawi AH, Owaifeer AM, Mofti A, Al-Shahwan S, Jadaan I, Malik R. Comparison of the Ahmed and Baerveldt glaucoma drainage implants in the treatment of primary congenital glaucoma. J Pediatr Ophthalmol Strabismus. 2023;60:448\u201354.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"1076_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aopr.2022.10.004","volume":"3","author":"Q Qin","year":"2023","unstructured":"Qin Q, Zhang C, Yu N, Jia F, Liu X, Zhang Q, et al. Development and material characteristics of glaucoma surgical implants. Adv Ophthalmol Pract Res. 2023;3:1\u2013179.","journal-title":"Adv Ophthalmol Pract Res"},{"key":"1076_CR19","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/eye.2014.140","volume":"28","author":"M Papadopoulos","year":"2014","unstructured":"Papadopoulos M, Edmunds B, Fenerty C, Khaw PT. Childhood glaucoma surgery in the 21st Century. Eye. 2014;28:931\u201343.","journal-title":"Eye"},{"key":"1076_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1136\/bjo.83.2.151","volume":"83","author":"A Azuara-Blanco","year":"1999","unstructured":"Azuara-Blanco A, Wilson RP, Spaeth GL, Schmidt CM, Augsburger JJ. Filtration procedures supplemented with mitomycin C in the management of childhood glaucoma. Br J Ophthalmol. 1999;83:151\u20136.","journal-title":"Br J Ophthalmol"},{"key":"1076_CR21","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/IJG.0b013e3181efbea5","volume":"20","author":"RAR Mahdy","year":"2011","unstructured":"Mahdy RAR. Adjunctive use of bevacizumab versus mitomycin C with Ahmed valve implantation in treatment of pediatric glaucoma. J Glaucoma. 2011;20:458\u201363.","journal-title":"J Glaucoma"},{"key":"1076_CR22","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1016\/j.ophtha.2009.03.030","volume":"116","author":"F Al-Mobarak","year":"2009","unstructured":"Al-Mobarak F, Khan AO. Two-year survival of Ahmed valve implantation in the first 2 years of life with and without intraoperative Mitomycin-C. Ophthalmology. 2009;116:1862\u20135.","journal-title":"Ophthalmology"},{"key":"1076_CR23","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1136\/bjo.2004.049015","volume":"89","author":"AA Al-Torbak","year":"2005","unstructured":"Al-Torbak AA. Endophthalmitis associated with the Ahmed glaucoma valve implant. Br J Ophthalmol. 2005;89:454\u20138.","journal-title":"Br J Ophthalmol"},{"key":"1076_CR24","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1159\/000525985","volume":"13","author":"E Milla","year":"2022","unstructured":"Milla E, Izquierdo J, Sanchez Dalmau B. Surgical repair of the extrusion of the body of a PAUL Implant for Glaucoma. Case Rep Ophthalmol. 2022;13:671\u20137.","journal-title":"Case Rep Ophthalmol"},{"key":"1076_CR25","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1177\/1120672120925641","volume":"31","author":"M Nardi","year":"2021","unstructured":"Nardi M, Maglionico MN, Posarelli C, Figus M. Managing Ahmed glaucoma valve tube exposure: surgical technique. Eur J Ophthalmol. 2021;31:778\u201381.","journal-title":"Eur J Ophthalmol"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-024-01076-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-024-01076-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-024-01076-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T21:03:12Z","timestamp":1727125392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-024-01076-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1076"],"URL":"https:\/\/doi.org\/10.1007\/s10384-024-01076-0","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,27]]},"assertion":[{"value":"6 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M. Karapapak, None; A. Olgun, None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}